Topics
PSMO 20TH MIDYEAR CONVENTION
Bevacizumab Biosimilar: Clinical and Scientific Considerations
PSMO 20TH MIDYEAR CONVENTION
Confident Conversations on CDK4/6i
PSMO 20TH MIDYEAR CONVENTION
Use of Monoclonal Antibodies as Pre – Exposure Prophylaxis Against COVID 19 in Chronic Kidney Patients
PSMO 20TH MIDYEAR CONVENTION
Mutation Matters: Reimagining Treatment Sequencing in HR+ HER2- aBC
PSMO 20TH MIDYEAR CONVENTION
The Power of Doublet with Lenvatinib: Extending Survival to Multiple Cancers